Literature DB >> 20950069

Economic evaluation guidelines in Latin America: a current snapshot.

Federico Augustovski1, Osvaldo Ulises Garay, Andres Pichon-Riviere, Adolfo Rubinstein, Joaquín E Caporale.   

Abstract

Economic evaluation guidelines are widespread in developed countries with fourth hurdle systems but as of yet not in Latin America. In the present article, a systematic search was conducted in order to retrieve regional guidelines in PubMed, Latin American and Caribbean Health Sciences Literature (LILACS) and the gray literature. Four national guidelines were found: Brazil, Colombia, Cuba and Mexico. We report a thorough review of these documents, as well as a comparison among them. We conclude that, despite some differences found, they are broadly similar, and are broadly in accordance with international documents. The existence of these documents, together with other experiences in the region that explicitly use economic evaluation information for health decision making clearly shows that this global tendency is gaining momentum in Latin America, although there is still a long way to go. In the near future we will be able to see if these documents were successfully used and applied for transparent and evidence-based decision making.

Mesh:

Year:  2010        PMID: 20950069     DOI: 10.1586/erp.10.56

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  7 in total

1.  Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis.

Authors:  Andrés Pichon-Riviere; Demián Glujovsky; Osvaldo Ulises Garay; Federico Augustovski; Agustin Ciapponi; Magdalena Serpa; Fernando Althabe
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

2.  Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs.

Authors:  Adolfo Rubinstein; Natalia Elorriaga; Osvaldo U Garay; Rosana Poggio; Joaquin Caporale; Maria G Matta; Federico Augustovski; Andres Pichon-Riviere; Dariush Mozaffarian
Journal:  Bull World Health Organ       Date:  2015-06-23       Impact factor: 9.408

3.  Health economic evaluation of Human Papillomavirus vaccines in women from Venezuela by a lifetime Markov cohort model.

Authors:  Ariel Esteban Bardach; Osvaldo Ulises Garay; María Calderón; Andrés Pichón-Riviére; Federico Augustovski; Sebastián García Martí; Paula Cortiñas; Marino Gonzalez; Laura T Naranjo; Jorge Alberto Gomez; Joaquín Enzo Caporale
Journal:  BMC Public Health       Date:  2017-02-02       Impact factor: 3.295

4.  Measuring the Benefits of Healthcare: DALYs and QALYs - Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions.

Authors:  Andres Pichon-Riviere; Federico Augustovski; Lisandro D Colantonio; Julieta Galante; Ariel Bardach; Joaquín E Caporale; Víctor Zárate; Ling Hsiang Chuang; Paul Kind
Journal:  Int J Health Policy Manag       Date:  2018-02-01

5.  [Health impact assessment of the Program Healthy Centers in the Autonomous City of Buenos Aires, ArgentinaAvaliação do impacto na saúde do Programa Estações Saudáveis na Cidade Autônoma de Buenos Aires, Argentina].

Authors:  Natalia Elorriaga; Osvaldo Ulises Garay; María Belizán; Verónica Beatriz González; María Laura Rossi; Martin Chaparro; Joaquín E Caporale; Marina De Ruggiero; María Cecilia Antún; Andrés Pichon-Riviere; Adolfo Rubinstein; Vilma Irazola; Federico Augustovski
Journal:  Rev Panam Salud Publica       Date:  2018-09-24

6.  Cost-Utility and Budget Impact Analysis of Implementing Anticoagulation Clinics and Point-of-Care Monitoring Devices in Anticoagulated Patients in Argentina.

Authors:  Osvaldo Ulises Garay; Gonzalo Guiñazú; Yolanda Patricia Adamczuk; Cristina Duboscq
Journal:  Pharmacoecon Open       Date:  2022-07-14

7.  Improving the monitoring of chronic heart failure in Argentina: is the implantable pulmonary artery pressure with CardioMEMS Heart Failure System cost-effective?

Authors:  Andrea Alcaraz; Carlos Rojas-Roque; Daniela Prina; Juan Martín González; Andrés Pichon-Riviere; Federico Augustovski; Alfredo Palacios
Journal:  Cost Eff Resour Alloc       Date:  2021-07-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.